financetom
Business
financetom
/
Business
/
Fosun unit to divest 40% stake in Portugal's Luz Saude to Macquarie-linked firm
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fosun unit to divest 40% stake in Portugal's Luz Saude to Macquarie-linked firm
Sep 4, 2025 5:44 PM

(Reuters) -Hong Kong-listed Chinese conglomerate Fosun International ( FOSUF ) said on Friday its unit had agreed to sell a 40% stake in Portugal-based hospital operator Luz Saude for 310 million euros ($362.92 million) to an entity linked to Australia's Macquarie Group ( MCQEF ).

Fosun ( FOSUF )-controlled Portuguese insurer Fidelidade inked a deal with MEIF 7 Med Holdings to dispose of some of its stake in the hospital operator, the Hong Kong-listed company said in a statement.

MEIF 7 Med Holdings, which is affiliated with Macquarie European Infrastructure Fund 7, is managed by Macquarie Asset Management, the asset management arm of Australian financial services group Macquarie.

Following the completion of the deal, Fidelidade will retain 59.86% of shares and voting rights in Luz Saude, Fosun ( FOSUF ) added.

The stake sale comes amid growing interest in Portugal's healthcare sector from private equity firms.

Lusiadas Saude, one of the country's leading hospital operators, was acquired by France's Vivalto Sante in 2022, while Spain's MCH Private Equity purchased a minority stake in Sanfil-Global Health earlier this year.

Luz Saude is among Portugal's largest private healthcare groups and operates 30 hospitals, clinics and nursing homes across the country.

Earlier last year, Fidelidade had considered listing Luz Saude on the Lisbon stock exchange but shelved the plan after assessing instability in capital markets, exacerbated by geopolitical tensions in the Middle East.

Fosun ( FOSUF ) began its investment in Portugal in May 2014, acquiring Fidelidade for about 1 billion euros and currently owns 85% of the company.

($1 = 0.8542 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mobix Labs and Peraso Enter Cooperative Discussions Toward a Potential Acquisition
Mobix Labs and Peraso Enter Cooperative Discussions Toward a Potential Acquisition
Nov 3, 2025
IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ( MOBX ) , a rapidly growing fabless semiconductor and connectivity company serving the defense, aerospace, and high-reliability markets, today announced that it has entered into a mutual confidentiality agreement with Peraso, Inc. ( PRSO ) to begin cooperative discussions toward a potential acquisition. The agreement creates a structured and...
Sportradar Announces Close of Acquisition of IMG ARENA and Its Strategic Portfolio of Global Sports Betting Rights
Sportradar Announces Close of Acquisition of IMG ARENA and Its Strategic Portfolio of Global Sports Betting Rights
Nov 3, 2025
ST. GALLEN, Switzerland, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sportradar Group AG ( SRAD ) (“Sportradar” or the “Company”) today announced it has completed its acquisition of IMG ARENA and its global sports betting rights portfolio from Endeavor Group Holdings, Inc. and OB Global Holdings, LLC. The closing marks a milestone in Sportradar’s growth strategy, further strengthening and differentiating its...
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
Nov 3, 2025
HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. ( BNTC ) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announces the appointment of Dr. Sharon Mates to the board of directors (BOD) of the Company, effective November 2, 2025....
BRIEF-Power Management Firm Eaton Strikes $9.5 Billion Deal For Boyd Thermal
BRIEF-Power Management Firm Eaton Strikes $9.5 Billion Deal For Boyd Thermal
Nov 3, 2025
Nov 3 (Reuters) - Eaton Corporation PLC ( ETN ): * EATON SIGNS AGREEMENT TO ACQUIRE BOYD THERMAL, EXPANDING SOLUTIONS FOR DATA CENTER CUSTOMERS TO INCLUDE CRITICAL LIQUID COOLING TECHNOLOGY * EATON CORPORATION PLC ( ETN ) - EATON WILL PAY $9.5 BILLION * EATON CORPORATION PLC ( ETN ): EATON WILL PAY $9.5 BILLION * EATON CORPORATION PLC (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved